RVMD
Revolution Medicines is a biopharmaceutical company focused on discovering, developing, and delivering targeted medicines for cancer, with a particular emphasis on Ras-driven or Ras-addicted cancers. The company pursues precision oncology through its pipeline and science programs, aiming to outsmart cancer by targeting oncogenic pathways. Headquartered in Redwood City, California, Revolution Medicines emphasizes translational science and novel targeted therapies to treat patients worldwide.
No recent deals for this company.